Explore more publications!
Louisiana Health Daily
Got News to Share?

Louisiana Health Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Louisiana Health Daily.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on November 11, 2025

Quoin Pharmaceuticals Announces Achievement of Topical Rapamycin Target Loadings for Two Proprietary Delivery Technologies
November 11, 2025

Quoin Pharmaceuticals Announces Achievement of Topical Rapamycin Target Loadings for Two Proprietary Delivery Technologies

Indeterminate GlobeNewswire
Grace Therapeutics Announces Abstract Accepted for Presentation at Society of Vascular and Interventional Neurology Annual Meeting
November 11, 2025

Grace Therapeutics Announces Abstract Accepted for Presentation at Society of Vascular and Interventional Neurology Annual Meeting

Indeterminate GlobeNewswire
iRhythm Technologies Announces Publication of Large-Scale Study in Heart Rhythm and New Data Presented at AHA Scientific Sessions 2025
November 11, 2025

iRhythm Technologies Announces Publication of Large-Scale Study in Heart Rhythm and New Data Presented at AHA Scientific Sessions 2025

Indeterminate GlobeNewswire
Pacira BioSciences to Participate in Fireside Chat at Two Upcoming Healthcare Conferences
November 11, 2025

Pacira BioSciences to Participate in Fireside Chat at Two Upcoming Healthcare Conferences

Indeterminate GlobeNewswire
Turn Therapeutics’ GX-03 Technology Named as One of “Five Novel Mechanisms Reshaping Atopic Dermatitis Treatment” by Patient Care Online Magazine
November 11, 2025

Turn Therapeutics’ GX-03 Technology Named as One of “Five Novel Mechanisms Reshaping Atopic Dermatitis Treatment” by Patient Care Online Magazine

Indeterminate GlobeNewswire
Prime Medicine to Present at Jefferies Global Healthcare Conference
November 11, 2025

Prime Medicine to Present at Jefferies Global Healthcare Conference

Indeterminate GlobeNewswire
Solid Biosciences to Participate at Upcoming Investor Conferences
November 11, 2025

Solid Biosciences to Participate at Upcoming Investor Conferences

Indeterminate GlobeNewswire
March Biosciences Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for MB-105 in Relapsed/Refractory CD5-Positive T-Cell Lymphoma
November 11, 2025

March Biosciences Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for MB-105 in Relapsed/Refractory CD5-Positive T-Cell Lymphoma

Indeterminate GlobeNewswire
Oncotelic Therapeutics and Sapu Bioscience Announce Publication on Sub-15 nm Nanoparticles in International Journal of Molecular Sciences
November 11, 2025

Oncotelic Therapeutics and Sapu Bioscience Announce Publication on Sub-15 nm Nanoparticles in International Journal of Molecular Sciences

Indeterminate GlobeNewswire
Pluri Partners with Miss Universe Skincare Introducing Exosome-Enhanced Regenerative Skincare
November 11, 2025

Pluri Partners with Miss Universe Skincare Introducing Exosome-Enhanced Regenerative Skincare

Indeterminate GlobeNewswire
BrainsWay Reports Third Quarter 2025 Financial Results and Operational Highlights
November 11, 2025

BrainsWay Reports Third Quarter 2025 Financial Results and Operational Highlights

Indeterminate GlobeNewswire
CorVel Earns Spot on TIME’s America’s Growth Leaders 2026 List — the Only Company in Its Industry Recognized
November 11, 2025

CorVel Earns Spot on TIME’s America’s Growth Leaders 2026 List — the Only Company in Its Industry Recognized

Indeterminate GlobeNewswire
Zenas BioPharma to Present at Upcoming Healthcare Investor Conferences
November 11, 2025

Zenas BioPharma to Present at Upcoming Healthcare Investor Conferences

Indeterminate GlobeNewswire
AC Immune to Present at the Jefferies 2025 London Healthcare Conference
November 11, 2025

AC Immune to Present at the Jefferies 2025 London Healthcare Conference

Indeterminate GlobeNewswire
NeurAxis Reports Strong Third Quarter 2025 Financial Results Driven by a 22% Growth in Revenues
November 11, 2025

NeurAxis Reports Strong Third Quarter 2025 Financial Results Driven by a 22% Growth in Revenues

Indeterminate GlobeNewswire
Ernexa Therapeutics to Present at Oxford Global’s Cell 2025
November 11, 2025

Ernexa Therapeutics to Present at Oxford Global’s Cell 2025

Indeterminate GlobeNewswire
Flower by Edie Parker Announces Exclusive Partnership with Verano to Launch Cannabis Line in Florida with Campaign Starring Miami Native and Grammy-Nominated Rapper JT
November 11, 2025

Flower by Edie Parker Announces Exclusive Partnership with Verano to Launch Cannabis Line in Florida with Campaign Starring Miami Native and Grammy-Nominated Rapper JT

Indeterminate GlobeNewswire
Solésence Reports Third Quarter 2025 Financial Results
November 11, 2025

Solésence Reports Third Quarter 2025 Financial Results

Indeterminate GlobeNewswire
New Peer-Reviewed Publications Highlight Effectiveness of OMNI® Surgical System with TruSync™ Technology in Reducing IOP and Medication Usage in Cataract Combination Procedures, Standalone Procedures, and in African Americans
November 11, 2025

New Peer-Reviewed Publications Highlight Effectiveness of OMNI® Surgical System with TruSync™ Technology in Reducing IOP and Medication Usage in Cataract Combination Procedures, Standalone Procedures, and in African Americans

Indeterminate GlobeNewswire
Soleno Therapeutics Announces Entry Into $100 Million Accelerated Share Repurchase Agreement
November 11, 2025

Soleno Therapeutics Announces Entry Into $100 Million Accelerated Share Repurchase Agreement

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions